Lucence
PrivateLast Round
Series A
Extension
Nov 10, 2023
Total Funding Raised
$74.35M
Company Overview
Lucence is a precision oncology company that develops non-invasive liquid biopsy tests for early cancer detection and treatment selection.
Sector
Healthcare & Life Sciences
Verticals
Precision Medicine, Biotechnology, Healthcare Analytics
Business Model
B2B
Customer Profile
Services & Consulting, Government Contracts
AI Layer
Application
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Lucence Comps
Public and private peers based on sector, stage, and business model.
Lucence Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Series A Extension | Nov 10, 2023 | ||||
| Series A | Nov 20, 2019 |
Key People
Founding team and executive leadership
Lucence Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Chen Capital Ventures | Series A Extension |
| Heliconia Capital | Series A, Series A Extension |
| SGInnovate | Series A |
| Openspace Capital | Series A Extension |
Market signals
Structured signals derived from secondary market and firmographic data.
- Oct 15, 2025
Grew 18% QoQ, from 83 to 98 employees.
- Jul 1, 2025
Monthly visitors increased 88% MoM, reaching 3,000.
Lucence Filings
SEC and related filings with document metadata.
| Typed | Date | Amount Offered | Amount Sold | Filling | Pages | Download |
|---|---|---|---|---|---|---|
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Frequently Asked Questions
Common questions about Lucence's valuation, stock price, and market status.
